Patent · US Active

Interleukin-2 agents and uses thereof

US12297249B2 · kind B2 · utility

0Cited by
41References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 25, 2024
Grant dateMay 13, 2025
Priority date
Expiry dateApr 2, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

IL-2 agents that comprise IL-2 variants are disclosed as well as methods, compositions, and uses thereof. The IL-2 agents described herein can be used to treat and/or prevent various disorders and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.